InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Turka Laurence A., Directeur Scientifique. Director active across 1 company, notably Rubius Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Laurence A. Turka is the Chief Scientific Officer at Rubius Therapeutics, Inc. He is responsible for leading the company's research and development initiatives. His scientific expertise is essential in guiding innovative projects and ensuring the success of therapies developed by Rubius.